Court Revives Bristol Myers Drug Lawsuit
A federal appeals court has revived a 6.7 billion dollar lawsuit accusing Bristol Myers Squibb of delaying approvals for three drugs. The decision overturns a previous dismissal and restores claims brought by a trustee for former Celgene shareholders.
Related Assets: